PipelineReview.com21h
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...
MMA Mania on MSN15h
Bad Marriage! PPVs ‘Way, Way Down’ Under ESPN
Accusations of poor performance are starting to fly on both sides as ESPN and UFC look like they’re getting ready to part ...